LAB
Standard BioTools Inc. · Healthcare
Casdin Partners Master Fund, L.P. bought $1.9M of Standard BioTools Inc.
Director and 10% owner
Bought$1,948,680
$1.62Price
1,200,000Shares
+2%Stake
What LAB did for a copier
- $1,000 copied at Wed, Aug 7 open, $1.69
- $1,249
- S&P 500, same days
- +8.0%
Measured over 30 trading days, to the Sep 19 close.
Casdin Partners Master Fund, L.P.'s record
18 other buys with 3 months of prices since 2020: on average −10.8% against the S&P 500, and 6 of 18 beat it.
We're building an app that can copy buys like this into your own brokerage. Join the waitlist
Traded Fri, Aug 2. Filed Tue, Aug 6, 5:58 PM ET, after the close. Returns use the Aug 7 open and the Sep 19 close. Not investment advice.